NVDA $APLD SE STOCK ANALYSIS 📈 OCTOBER 22
3 extracted signals · 0 resolved · 3 still active
Overkill TradingIndependent analyst profile- Source published
- 22 Oct 2026, 23:51 UTC
- Recorded by Tahlil Plus
- 23 Oct 2026, 02:40 UTC
AI-generated source summary
The analysis focuses on three stocks: NVDA, APLD, and SE, using a weekly timeframe. For NVDA, the speaker notes that the price is currently above the 4-year moving average and has failed to make new highs, suggesting a potential correction. While the current price is around $213.09, the speaker implies a target around $235.00, but the analysis is bearish, with a fail bound below $170.00. For APLD, the current price is around $19.08, and the speaker believes it is in a good setup, looking for a target of $25.00 with a bullish prediction, and a fail bound below $15.00. SE is currently trading around $77.18, and despite a recent strong sell-off, the speaker sees a potential bullish setup with a target of $100.00 and a fail bound below $70.00. The speaker emphasizes buying before mania and selling into greed, referencing a market cycle chart, and uses indicators like moving averages and RSI-like oscillators to identify potential entry and exit points.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
3 signals remain active.
Overkill Trading
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.